Drugs / tyrosinase-related protein-2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00022438 | Jun 2001 → Aug 2004 | cutaneous melanoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tyrosinase-related protein-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00022438 ↗ |
| Route | Subcutaneous | “TRP-2:180-188 peptide vaccine emulsified with Montanide ISA-51 subcutaneously (SC)” NCT00022438 ↗ |